S&P Global Ratings anticipates that ModivCare will fall short of its previous expectations for 2024 and 2025, leading to ongoing cash flow deficits. The company's reliance on normalized utilization ...

Investing.com -- Reddit shares gained 3.5% after-hours Tuesday following Piper Sandler's recognition of a new feature that streamlines ad campaign imports from Meta Platforms Inc (NASDAQ: META ).’s ...

F5 was up more than 12% in recent afterhours trading following the report. For the three months ended Dec. 31, the company reported adjusted earnings of $3.84 per diluted share on revenue of $766 ...

On Tuesday, the White House announced a new initiative to encourage federal workers who are reluctant to return to office ...

The positive results have also led Qorvo to project an optimistic outlook for the fourth quarter of 2025, with expected EPS ranging from $0.90 to $1.10, against the consensus of $0.86. Revenue ...

NVIDIA (NASDAQ: NVDA) shares bounced back strongly Tuesday following Monday’s DeepSeek-related sell-off, which whipped out a ...

Investing.com -- Steven Cohen, CEO of Point72, has expressed his expectation that markets could reach their peak within the next few months if this hasn't occurred already, according to headlines from ...

Shares of Tectonic plummeted 41% Tuesday following news that a similar drug developed by Eli Lilly (NYSE: LLY) for chronic ...

Investing.com -- Shares of Alibaba (NYSE: NYSE: BABA) climbed 2.8% as the company's latest AI model, Qwen2.5-Max, garnered ...

The FDA's approval is based on the results of the FLOW phase 3b kidney outcomes trial. The trial revealed that Ozempic® 1 mg significantly lowered the relative risk of worsening kidney disease, kidney ...

"Around 70% of the [BofA] Hedge Funds' USD position built over Q4 and around 75% via SDR FX options remain, in line with the ...

Investing.com -- In a recent development, the CEO of OpenAI, Sam Altman, has hinted at an exciting upcoming phase of ...